$1.85
0.000.00%
Pre-Market: 7:45 PM EDT
Comments
Loading...
C4 Therapeutics Stock Guidance | NASDAQ:CCCC | Benzinga
C4 Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics Inc (CCCC) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for C4 Therapeutics (CCCC)?
There have been no specific sales or earnings guidance reported for C4 Therapeutics in recent months.
Browse guidance and forecast on all stocks.